RadNet, Inc. (RDNT): Price and Financial Metrics


RadNet, Inc. (RDNT)

Today's Latest Price: $19.04 USD

0.27 (1.44%)

Updated Dec 2 4:00pm

Add RDNT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

RDNT Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for RDNT is 6.77 -- better than 95.1% of US stocks.
  • Of note is the ratio of RadNet Inc's sales and general administrative expense to its total operating expenses; merely 0.47% of US stocks have a lower such ratio.
  • For RDNT, its debt to operating expenses ratio is greater than that reported by 96.24% of US equities we're observing.
  • If you're looking for stocks that are quantitatively similar to RadNet Inc, a group of peers worth examining would be SNR, STNG, FCPT, GTN, and BRG.
  • RDNT's SEC filings can be seen here. And to visit RadNet Inc's official web site, go to www.radnet.com.

RDNT Stock Price Chart Interactive Chart >

Price chart for RDNT

RDNT Price/Volume Stats

Current price $19.04 52-week high $23.45
Prev. close $18.77 52-week low $5.81
Day low $18.27 Volume 182,945
Day high $19.23 Avg. volume 335,221
50-day MA $16.81 Dividend yield N/A
200-day MA $15.64 Market Cap 983.15M

RadNet, Inc. (RDNT) Company Bio


RadNet, Inc. provides outpatient diagnostic imaging services in the United States. The company was founded in 1985 and is based in Los Angeles, California.

RDNT Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$19.04$73.51 302%

Below please find a table outlining a discounted cash flow forecast for RDNT, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that RadNet Inc ranked in the 74th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for RadNet Inc ended up being:

  • 45% of the company's capital comes from equity, which is greater than merely 20.14% of stocks in our cash flow based forecasting set.
  • RadNet Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
  • Relative to other stocks in its sector (Healthcare), RadNet Inc has a reliance on debt greater than 89.59% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%294%
1%298%
2%302%
3%306%
4%310%
5%314%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as RDNT, try CSTL, MYL, UHS, CI, and ABBV.


RDNT Latest News Stream


Event/Time News Detail
Loading, please wait...

RDNT Latest Social Stream


Loading social stream, please wait...

View Full RDNT Social Stream

Latest RDNT News From Around the Web

Below are the latest news stories about RadNet Inc that investors may wish to consider to help them evaluate RDNT as an investment opportunity.

Radiology Services Market Is Thriving Worldwide By Top Vendors Siemens, 4ways Limited, MEDNAX, Inc., Everlight Radiology, RadNet, Inc., Koninklijke Philips N.V., Sonic Healthcare

Radiology Services Market is projected to register a healthy CAGR of 12.5% in the forecast period of 2019 to 2026. Global Radiology Services Market By Type (Product, Services), Procedure (Conventional, Digital), Patient Age(Adults, Pediatric), Radiation Type(Diagnostics, Interventional Radiology), Application (Cardiovascular, Oncology,

OpenPR | September 29, 2020

RadNet expands its revolving credit facility to $195M

RadNet (RDNT) has amended its senior secured first lien credit agreement to increase the amount of the revolving commitments thereunder by $57.5M, bringing the total now to $195M revolving credit facility and $630.4M of first lien term loans, each having a maturity date of July 1, 2023. Mark Stolper, EVP...

Seeking Alpha | August 31, 2020

RadNet EPS beats by $0.28, revenue in-line

RadNet (RDNT): Q2 Non-GAAP EPS of -$0.16 beats by $0.28; GAAP EPS of -$0.21 beats by $0.20.Revenue of $190.57M (-34.1% Y/Y) in-line.Press Release...

Seeking Alpha | August 10, 2020

RadNet Inc (RDNT) Q2 2020 Earnings Call Transcript | The Motley Fool

RDNT earnings call for the period ending June 30, 2020.

The Motley Fool | August 10, 2020

RadNet and Hologic Announce Collaboration to Advance the Development of Artificial Intelligence Tools in Breast Health

Collaboration will include data sharing, R&D and an upgrade of RadNet’s fleet of Hologic mammography systems to state-of-the-art imaging technology

GlobeNewswire | August 6, 2020

Read More 'RDNT' Stories Here

RDNT Price Returns

1-mo 25.93%
3-mo 27.61%
6-mo 6.61%
1-year -6.21%
3-year 88.51%
5-year 207.10%
YTD -6.21%
2019 99.61%
2018 0.69%
2017 56.59%
2016 4.37%
2015 -27.63%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9692 seconds.